artesunic acid has been researched along with Adenomatous Polyposis Coli, Familial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, G; Hamoya, T; Iizumi, Y; Kishimoto, S; Komiya, M; Kondo, T; Matsuzawa, Y; Miki, K; Mutoh, M; Narita, T; Sakai, T; Toshima, J; Wakabayashi, K; Watanabe, K | 1 |
1 other study(ies) available for artesunic acid and Adenomatous Polyposis Coli, Familial
| Article | Year |
|---|---|
Artesunate inhibits intestinal tumorigenesis through inhibiting wnt signaling.
Topics: Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Animals; Artesunate; Carcinogenesis; Cell Line, Tumor; Cell Nucleus; Disease Models, Animal; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hepatocyte Nuclear Factor 1-alpha; Humans; Intestinal Mucosa; Male; Mice; Mice, Transgenic; Mutation; Promoter Regions, Genetic; ran GTP-Binding Protein; T Cell Transcription Factor 1; Transcriptional Activation; Wnt Signaling Pathway | 2021 |